BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 283 filers reported holding BIONTECH SE in Q2 2021. The put-call ratio across all filers is 1.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,484,520 | -25.4% | 36,000 | -10.0% | 0.06% | -38.1% |
Q4 2022 | $6,008,800 | -71.4% | 40,000 | -74.4% | 0.10% | -71.2% |
Q3 2022 | $21,041,000 | +41.1% | 156,000 | +56.0% | 0.36% | +40.4% |
Q2 2022 | $14,910,000 | +16.6% | 100,000 | +33.3% | 0.26% | +5.3% |
Q1 2022 | $12,792,000 | -27.0% | 75,000 | +10.3% | 0.25% | -13.9% |
Q4 2021 | $17,530,000 | +23.5% | 68,000 | +30.8% | 0.29% | +19.6% |
Q3 2021 | $14,195,000 | -0.9% | 52,000 | -18.8% | 0.24% | -6.2% |
Q2 2021 | $14,328,000 | -52.5% | 64,000 | -76.8% | 0.26% | -63.0% |
Q1 2021 | $30,136,000 | +56.6% | 276,000 | +16.9% | 0.69% | +5.8% |
Q4 2020 | $19,239,000 | -17.3% | 236,000 | -29.8% | 0.65% | -22.5% |
Q3 2020 | $23,261,000 | – | 336,000 | – | 0.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
Systrade AG | 50,000 | $5,432,000 | 4.70% |
Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
AtonRa Partners | 4,707 | $511,368 | 1.07% |
Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |